Solara Active Pharma Sciences Complete Financial Statements
In FY2026, Solara Active Pharma Sciences (SOLARA) reported revenue ₹393 Cr, net profit ₹10 Cr and EPS ₹2.20, with a net profit margin of 2.5% and ROE of 0.8%. Full financial statements from FY2018 to FY2026 (9 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see SOLARA screener.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SOLARA Revenue, Net Profit & EBITDA — Year-on-Year Growth
SOLARA YoY (Mar 2025 vs Mar 2026) — revenue +40.9%, net profit +600.0%, EBITDA +23.5%, expenses +44.7%. Review SOLARA PE ratio trends to evaluate earnings-based valuation against sector peers.
SOLARA Income Statement — Revenue, EBITDA & Net Profit
Solara Active Pharma Sciences revenue ₹393 Cr, EBITDA ₹63 Cr, net profit ₹10 Cr, EPS ₹2.20 (2026) — net profit margin 2.5%. Explore SOLARA fundamental worth to estimate fundamental worth using multiple valuation models.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 393 | 314 | 279 | 320 | 349 | 347 | 301 | 364 | 302 | 426 | 385 | 354 | 212 | 342 | 367 | 337 | 402 | 405 | 454 | 412 | 105 | 404 | 309 | 353 | 435 | 356 | 392 | 335 | 350 | 344 | 303 | 360 |
| Expenses | 330 | 279 | 228 | 262 | 318 | 286 | 412 | 322 | 243 | 393 | 332 | 333 | 436 | 311 | 349 | 318 | 350 | 330 | 345 | 315 | 199 | 300 | 247 | 265 | 321 | 283 | 321 | 267 | 266 | 295 | 263 | 294 |
| EBITDA | 63 | 35 | 51 | 58 | 31 | 62 | -111 | 43 | 59 | 34 | 53 | 21 | -224 | 31 | 18 | 20 | 52 | 75 | 109 | 97 | -94 | 104 | 62 | 88 | 114 | 73 | 71 | 68 | 84 | 49 | 40 | 66 |
| Operating Profit Margin % | 15.00% | 11.00% | 17.00% | 18.00% | 9.00% | 18.00% | -38.00% | 12.00% | 19.00% | 8.00% | 13.00% | 5.00% | -106.00% | 8.00% | 3.00% | 4.00% | 11.00% | 18.00% | 22.00% | 22.00% | -98.00% | 25.00% | 17.00% | 24.00% | 25.00% | 19.00% | 17.00% | 19.00% | 23.00% | 14.00% | 13.00% | 17.00% |
| Depreciation | 26 | 25 | 24 | 24 | 26 | 25 | 25 | 25 | 25 | 26 | 27 | 26 | 26 | 29 | 28 | 28 | 28 | 28 | 27 | 28 | 28 | 28 | 24 | 26 | 27 | 24 | 23 | 23 | 24 | 19 | 19 | 21 |
| Interest | 28 | 21 | 29 | 24 | 23 | 28 | 31 | 31 | 27 | 24 | 22 | 25 | 25 | 22 | 22 | 23 | 24 | 17 | 25 | 19 | 18 | 19 | 20 | 20 | 21 | 20 | 22 | 19 | 19 | 20 | 18 | 23 |
| Profit Before Tax | 10 | -10 | -2 | 11 | -17 | 8 | -167 | -14 | 8 | -17 | 5 | -29 | -275 | -19 | -31 | -31 | 1 | 30 | 57 | 50 | -140 | 57 | 18 | 42 | 66 | 29 | 26 | 27 | 41 | 9 | 3 | 22 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 89 | 0 | 0 | 0 | 1 | -10 | 0 | -9 | -33 | -15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Net Profit | 10 | -10 | -2 | 11 | -17 | 8 | -255 | -14 | 8 | -17 | 4 | -19 | -275 | -10 | 2 | -17 | 0 | 30 | 57 | 50 | -140 | 57 | 18 | 42 | 66 | 29 | 26 | 27 | 41 | 9 | 3 | 22 |
| Earnings Per Share (₹) | 2.20 | -2.36 | -0.93 | 2.46 | -3.98 | 2.54 | -70.93 | -3.50 | 2.03 | -4.77 | 1.05 | -5.43 | -72.07 | -2.77 | 0.53 | -4.56 | 0.12 | 8.27 | 15.57 | 13.95 | -38.93 | 19.21 | 6.78 | 15.75 | 18.47 | 11.21 | 10.17 | 10.29 | 16.00 | 3.47 | 0.23 | 8.96 |
SOLARA Balance Sheet — Assets, Liabilities & Shareholders' Equity
SOLARA total assets ₹2,333 Cr, total equity ₹1,253 Cr, total liabilities ₹ Cr (2026) — ROE 0.8%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Total Assets | 2,333 | 2,232 | 2,351 | 2,899 | 2,945 | 2,614 | 2,154 | 1,960 | 1,822 |
| Current Assets | 858 | 729 | 801 | 1,188 | 1,239 | 1,058 | 672 | 648 | 608 |
| Fixed Assets | 1,077 | 1,193 | 1,268 | 1,364 | 1,356 | 1,382 | 1,397 | 1,218 | 1,086 |
| Capital Work in Progress | 205 | 280 | 256 | 239 | 239 | 88 | 41 | 40 | 72 |
| Investments | 318 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 1 |
| Other Assets | 0 | 757 | 825 | 1,295 | 1,350 | 1,144 | 716 | 702 | 663 |
| LIABILITIES | |||||||||
| Total Liabilities | |||||||||
| Current Liabilities | 183 | 191 | 172 | 296 | 354 | 232 | 333 | 344 | 315 |
| Non-Current Liabilities | |||||||||
| SHAREHOLDERS' EQUITY | |||||||||
| Total Equity | 1,253 | 1,097 | 937 | 1,502 | 1,527 | 1,593 | 1,090 | 960 | 769 |
| Share Capital | 45 | 40 | 36 | 36 | 36 | 36 | 27 | 26 | 25 |
| Reserves & Surplus | 1,208 | 1,054 | 898 | 1,464 | 1,489 | 1,553 | 963 | 826 | 739 |
SOLARA Cash Flow Statement — Operating, Investing & Financing
Solara Active Pharma Sciences operating cash flow ₹213 Cr, investing ₹-37 Cr, financing ₹-181 Cr, net cash flow ₹-5 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 213 | 109 | 156 | -242 | 156 | 242 | 166 | 49 |
| Investing Activities | -37 | -4 | -81 | -243 | -106 | -359 | -113 | -86 |
| Financing Activities | -181 | -106 | -113 | 334 | 93 | 97 | -23 | 68 |
| Net Cash Flow | -5 | 0 | -38 | -151 | 142 | -20 | 30 | 32 |